A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months

Abstract Background To evaluate the long-term efficacy and safety of fremanezumab over a 2-year period in a real-world setting. Methods This retrospective, observational, single-center cohort study included 165 patients with episodic migraine (EM) or chronic migraine (CM) who received fremanezumab t...

Full description

Bibliographic Details

Published in:	Neurological Research and Practice
Main Authors:	Shiho Suzuki, Keisuke Suzuki, Yasuo Haruyama, Hiroaki Fujita, Tomohiko Shiina, Saro Kobayashi, Mukuto Shioda, Ryotaro Hida, Koichi Hirata
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Subjects:	Migraine Migraine days per month Fremanezumab Calcitonin gene-related peptide monoclonal antibody
Online Access:	https://doi.org/10.1186/s42466-025-00395-y